Mirum Pharmaceuticals, Inc. (MIRM) Form 8-K Material Events
Mirum Pharmaceuticals, Inc. (MIRM) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MIRM
CIK: 1759425
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerSurita Goehl
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-14 | 2026-10-09 | 4 Filing | 0002155916-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-12 | 8-K | 0001759425-26-000051 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-06 | 4 Filing | 0001614740-26-000014 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-25 | 8-K | 0001759425-26-000049 | View SEC Doc Filr Page |
| 3 | 2026-09-22 | 2026-09-21 | 3 Filing | 0002155916-26-000003 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001197350-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | 4 Filing | 0001197350-26-000010 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-02 | 8-K | 0001759425-26-000047 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | 4 Filing | 0001974200-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0001614740-26-000013 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-008986 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008900 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-18 | 4 Filing | 0001974200-26-000012 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001950047-26-008352 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001274173-26-000210 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-11 | 4 Filing | 0001197350-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | 4 Filing | 0001614740-26-000012 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001950047-26-007935 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001950047-26-007862 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002080 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 Filing | 0001974200-26-000011 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001759425-26-000045 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001759425-26-000044 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001950047-26-007486 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 Filing | 0001614740-26-000011 | View SEC Doc Filr Page |